A business unit of the New York Blood Center Enterprises, Comprehensive Cell Solutions (CCS) is a cell and gene therapy-focused development and manufacturing. We provide critical capacity to an underserved population of early-stage developers, as well as expertise and strategic footprint for hospital treatment centers and pharmaceutical organizations.